Article
Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases - 1 Jan 2015
Gohil Devanshi J, Kothari Sweta T, Shinde Pramod S, Chintakrindi Anand S, Meharunkar Rhuta, Warke Rajas V, Kanyalkar Meena A, Chowdhary Abhay S, Deshmukh Ranjana A
Abstract excerpt
OBJECTIVE: From its first instance in 1977, resistance to amantadine, a matrix (M2) inhibitor has been increasing among influenza A/H3N2, thus propelling the use of oseltamivir, a neuraminidase (NA) inhibitor as a next line drug. Information on drug susceptibility to amantadine and neuraminidase inhibitors for influenza A/H3N2 viruses in India is limited with no published data from Mumbai. This study aimed at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
